Biostatistics, Epidemiology & Environmental Health Sciences: Faculty Publications
Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III)
Document Type
Article
Publication Date
4-15-2020
Publication Title
Abstract
As stated early in part I of the article, the focus of this article is for moderately COVID-19 affected ongoing trials where no formal interim analysis is planned. This requires a comprehensive assessment of each attribute of an estimand affected by unplanned trial modifications due to COVID-19. In addition, a formal process for adaptive statistical analysis planning, as described by Liu and Chi (2010a) and restated below, is also required.
Recommended Citation
Liu, Qing, Karl E. Peace.
2020.
"Statistical Considerations for Clinical Trials During COVID-19: Blinded Data Review for Adaptive Estimands (Part III)."
LinkedIn.
source: linkedin.com
https://digitalcommons.georgiasouthern.edu/bee-facpubs/145
Copyright
This work is archived and distributed under the repository's Standard Copyright and Reuse License (opens in new tab). End users may copy, store, and distribute this work without restriction. For all other uses, permission must be obtained from the copyright owners or their authorized agents.
